Pulmonary Aspergillosis: all 78 studies
Page 1 of 1. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.
- Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor ScoreRecruitingNCT07681583
- Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-beingRecruitingNCT06885905
- Multicenter Registration Study on Allergic Bronchopulmonary AspergillosisNot yet recruitingNCT06645210
- Breath Analysis for the Detection of Invasive Fungal InfectionsRecruitingNCT06537726
- A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary AspergillosisRecruitingNCT06174922Phase 3
- VOC in Breath Samples for the Diagnosis of IPARecruitingNCT05982912
- Early Diagnosis of Invasive Lung AspergillosisRecruitingNCT05860387
- Impact of A. Lumbricoides on Pulmonary Aspergillosis DevelopmentRecruitingNCT05783544Not applicable
- Chronic Pulmonary Aspergillosis and Ambisome Aerosol with ItraconazoleRecruitingNCT03656081Phase 3
- An Open-label Safety Study of PC945 (Opelconazole) Prophylaxis or Pre-emptive Therapy Against Pulmonary Aspergillosis in Lung Transplant Recipients (OPERA-S Study)CompletedNCT05037851Phase 2Results posted
- Investigating Treatment With Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)CompletedNCT04442269Phase 2Results posted
- Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare MoldsTerminatedNCT04240886Phase 2Results posted
- Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic SubjectsCompletedNCT04229303Phase 1Results posted
- Evaluate Safety and Efficacy of the Coadministration of Ibrexafungerp With Voriconazole in Patients With Invasive Pulmonary AspergillosisTerminatedNCT03672292Phase 2Results posted
- Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal TreatmentCompletedNCT03059992Phase 3Results posted
- A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)CompletedNCT01782131Phase 3Results posted
- Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute LeukaemiaCompletedNCT01615809Phase 2Results posted
- Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary AspergillosisCompletedNCT01222273Not applicableResults posted
- An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients With Cystic Fibrosis Complicated by Acute Bronchopulmonary Aspergillosis (ABPA)TerminatedNCT00787917Phase 4Results posted
- Voriconazole For Chronic Bronchopulmonary AspergillosisCompletedNCT00159822Phase 2/3Results posted
- Assessing Diagnostic Methods for Invasive Fungal Disease in Lung Transplant RecipientsCompletedNCT06654076
- Uniportal VATS Resection for Pulmonary Aspergilloma : Evaluation of Prognostic Factors in a Single Center ExperienceCompletedNCT06564727Not applicable
- iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamineCompletedNCT06244979Phase 2
- Allergic Bronchopulmonary Aspergillosis Prescreening StudyWithdrawnNCT05903612
- Voriconazole Inhalation Powder for the Treatment of Pulmonary AspergillosisNo longer availableNCT05897294
- LFD of Aspergillus Antigen in PaediatricsStatus unknownNCT05569824
- Non-invasive Tools to Diagnose Invasive Aspergillosis Infections in ICU Patients With COVID-19 and Other Conditions.Status unknownNCT05138666Not applicable
- A Prospective Study on Optimizing Treatment for ABPAStatus unknownNCT05129033Not applicable
- Pharmacological Evaluation of Antifungal in Chronic Pulmonary AspergillosisStatus unknownNCT05064605
- Pulmonary Aspergillosis in Tuberculosis PatientsActive, not recruitingNCT05045391
- Diagnosis of Invasive Pulmonary Aspergillosis, Specific Testing in Bronchial Secretions Versus Bronchoalveolar FluidStatus unknownNCT04848831
- A Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazole Versus Oral Voriconazole for Management of Treatment naïve Subjects With Chronic Pulmonary AspergillosisCompletedNCT04824417Phase 3
- Physiotherapy Treatment Plan in Allergic Bronchopulmonary Aspergillosis: Case ReportCompletedNCT04748900
- Isavuconazole for the Prevention of COVID-19-associated Pulmonary AspergillosisTerminatedNCT04707703Phase 3
- Prospective Observational Trial of IAPACompletedNCT04530799
- Immune Profiles in CF Fungal InfectionCompletedNCT04476758
- Non-invasive Diagnosis of Invasive Pulmonary Aspergillosis by Use of Biomarkers in Exhaled Breath CondensateCompletedNCT04358419
- Nebulised Liposomal Amphotericin for Invasive Pulmonary Aspergillosis (NAIFI01 Study)CompletedNCT04267497Phase 1
- Invasive Pulmonary Aspergillosis and Severe InfluenzaCompletedNCT04232956
- Deflazacort Vs. Prednisolone in Acute-stage ABPAActive, not recruitingNCT04227483Phase 2/3
- Prevalence of Influenza RelAted Invasive AspergillosisCompletedNCT04172610
- Benralizumab in the Treatment of Patients With Severe Asthma With ABPAWithdrawnNCT04108962Phase 4
- Clinical and Prognostic Comparisons Between Invasive Pulmonary Aspergillosis With or Without Invasive Tracheobronchitis During Severe Influenza: a Retrospective Multicenter Cohort Study.CompletedNCT04077697
- Study in Adult Asthmatic Patients With Allergic Bronchopulmonary AspergillosisTerminatedNCT03960606Phase 2
- Six Months Versus 12 Months of Oral Itraconazole Therapy for Management of Treatment naïve Subjects With CPACompletedNCT03920527Phase 3
- Cytokine Profile of Allergic Bronchopulmonary AspergillosisStatus unknownNCT03643185
- Azole-resistance in AspergillusCompletedNCT03443336
- Invasive Pulmonary Aspergillosis Complicating Influenza InfectionCompletedNCT03391492
- VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in AdultsTerminatedNCT03327727Phase 2
- Role of Thymus-And Activation-Regulated Chemokine (TARC) In Diagnosis Of Allergic Bronchopulmonary AspergillosisStatus unknownNCT03267394
- A Study Evaluating Vitamin D in Allergic Bronchopulmonary Aspergillosis Complicating AsthmaCompletedNCT03133299Phase 2/3
- Aspergillus-specific IgG Assays for the Diagnosis of Chronic Pulmonary Aspergillosis (CPA)-Multicenter StudyStatus unknownNCT03027089
- Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML PatientsWithdrawnNCT02856178Phase 1/2
- Lung MRI and Allergic Broncho-pulmonary Aspergillosis in Cystic FibrosisCompletedNCT02853175
- A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary AspergillosisCompletedNCT02440009Phase 2/3
- Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded).CompletedNCT02273661Phase 2
- Voriconazole for IPA in Chinese Patients With COPDStatus unknownNCT02234739Phase 4
- CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult PatientsStatus unknownNCT02100761
- Bronchoalveolar Lavage Lateral-Flow Device Test for Invasive Pulmonary Aspergillosis: a Multicenter StudyCompletedNCT02058316
- Diagnosis of Invasive Pulmonary Aspergillosis (IPA) in Critically Ill PatientsCompletedNCT01866020
- A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary AspergillosisCompletedNCT01857479Phase 2/3
- Protocol TARC-ABPACompletedNCT01710930Not applicable
- Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary AspergillosisCompletedNCT01621321Phase 2/3
- Diagnosing Pulmonary Aspergillosis in Patients With Hematological Malignancies: A Multicentre Prospective Evaluation of an Aspergillus PCR Assay and a Galactomannan ELISA in Bronchoalveolar Lavage SamplesCompletedNCT01430663
- Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary AspergillosisCompletedNCT01321827Phase 2/3
- Diagnosis of Invasive Pulmonary Aspergillosis by Direct Lung Tissue Aspergillus Galactomannan Antigen Detection From Aspirate by Ultrasound-guided Fine Needle AspirationStatus unknownNCT01301755
- Efficacy Of Itraconazole In Chronic Cavitary Pulmonary AspergillosisCompletedNCT01259336Phase 4
- Evaluation of Exhaled Breath Condensate in the Diagnosis of Invasive Pulmonary AspergillosisCompletedNCT01247142
- Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric SubjectsWithdrawnNCT01188759Phase 3
- Radiologic Features of Invasive Pulmonary AspergillosisCompletedNCT01178177
- Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic MalignancyTerminatedNCT01148160
- Value of Amphotericin B Inhalation for Prophylaxis of Invasive Pulmonary Aspergillosis After Renal TransplantationStatus unknownNCT00986713Phase 4
- Trial on the Efficacy and Safety of Two Different Glucocorticoid Dose Regimens in Allergic Bronchopulmonary AspergillosisCompletedNCT00974766Phase 2/3
- Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary ZygomycosisCompletedNCT00923832
- Evaluation of Bronchial Inflammation in Allergic Bronchopulmonary Aspergillosis (ABPA)CompletedNCT00906568
- Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPACompletedNCT00585364
- Prophylaxis of Fungal Invasive Infections in LeukemiaCompletedNCT00501098Phase 2
- Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary AspergillosisCompletedNCT00391014Phase 2